InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,550.62
(
0.76%
)
US TECH 100
19,753.60
(
0.57%
)
Dow Jones
39,315.27
(
0.02%
)
Brent Oil
87.61
(
0.31%
)
Bitcoin
56,244.97
(
-1.29%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

BioHunter

Send PM Follow Ignore
Followers 246
Posts 636
Boards Moderated 1
Alias Born 04/20/2007

BioHunter

Re: None

Thursday, 04/16/2015 9:01:13 AM

Thursday, April 16, 2015 9:01:13 AM

Post# of 97239
$MEIP $2PM. For those of us who held through the March MDS trail surprise, I suggest listening to yesterday's company presentation now on Mei Pharma website.

Company gives a good explanation as to why AML is working and MDS failed. Essentially AML patients are out of options so they do not drop out because of AE's, while MDS patients have options and by not knowing if they were on the study drug or placebo company saw 35% drop out early in trial due to AE, not enough time to see a drug effect.

Company is trading below cash and should move back towards 3 as we get ready for June Full data release on AML.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up